Search

Your search keyword '"Birov S"' showing total 17 results
Start Over Author "Birov S" Publication Year Range Last 50 years
17 results on '"Birov S"'

1. Digitally enabled health service for the integrated management of hypertension: A participatory user-centred design process

Author

De Luca, V, Lazic, V, Birov, S, Piesche, K, Beyhan, O, Pengo, M, Melgara, M, Sherman, M, Lilja, M, Balenovic, A, Parati, G, Triassi, M, Izzo, R, Iaccarino, G, Illario, M, De Luca V., Lazic V., Birov S., Piesche K., Beyhan O., Pengo M., Melgara M., Sherman M. H., Lilja M., Balenovic A., Parati G., Triassi M., Izzo R., Iaccarino G., Illario M., De Luca, V, Lazic, V, Birov, S, Piesche, K, Beyhan, O, Pengo, M, Melgara, M, Sherman, M, Lilja, M, Balenovic, A, Parati, G, Triassi, M, Izzo, R, Iaccarino, G, Illario, M, De Luca V., Lazic V., Birov S., Piesche K., Beyhan O., Pengo M., Melgara M., Sherman M. H., Lilja M., Balenovic A., Parati G., Triassi M., Izzo R., Iaccarino G., and Illario M.

Abstract

This article describes a user-centred approach taken by a group of five procurers to set specifications for the procurement of value-based research and development services for IT-sup-ported integrated hypertension management. The approach considered the unmet needs of patients and health systems of the involved regions. The procurers established a framework for requirements and a solution design consisting of nine building blocks, divided into three domains: service delivery, devices and integration, and health care organisation. The approach included the development of questionnaires, capturing patients’ and professionals’ views on possible system functionalities, and a template collecting information about the organisation of healthcare, professionals involved and existing IT systems at the procurers’ premises. A total of 28 patients diagnosed with hypertension and 26 professionals were interviewed. The interviewees identified 98 functional requirements, grouped in the nine building blocks. A total of nine use cases and their corresponding process models were defined by the procurers’ working group. As result, a digitally enabled integrated approach to hypertension has been designed to allow citizens to learn how to prevent the development of hypertension and lead a healthy lifestyle, and to receive comprehensive, individualised treatment in close collaboration with healthcare professionals.

Published
2021

2. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project)

Author

Bousquet, J., Agache, I., Aliberti, M. R., Angles, R., Annesi‐Maesano, I., Anto, J. M., Arnavielhe, S., Asayag, E., Bacci, E., Bedbrook, A., Bachert, C., Baroni, I., Barreto, B. A., Bedolla‐Barajas, M., Bergmann, K. C., Bertorello, L., Bewick, M., Bieber, T., Birov, S., Bindslev‐Jensen, C., Blua, A., Bochenska Marciniak, M., Bogus‐Buczynska, I., Bosnic‐Anticevich, S., Bosse, I., Bourret, R., Bucca, C., Buonaiuto, R., Burguete Cabanas, M. T., Caillaud, D., Caimmi, D. P., Caiazza, D., Camargos, P., Canfora, G., Cardona, V., Carriazo, A. M., Cartier, C., Castellano, G., Chavannes, N. H., Cecci, L., Ciaravolo, M. M., Cingi, C., Ciceran, A., Colas, L., Colgan, E., Coll, J., Conforti, D., Correia de Sousa, J., Cortés‐Grimaldo, R. M., Corti, F., Costa, E., Courbis, A. L., Cousein, E., Cruz, A. A., Custovic, A., Cvetkovski, B., Dario, C., da Silva, J., Dauvilliers, Y., De Blay, F., Dedeu, T., De Feo, G., De Martino, B., Demoly, P., De Vries, G., Di Capua Ercolano, S., Di Carluccio, N., Doulapsi, M., Dray, G., Dubakiene, R., Eller, E., Emuzyte, R., Espinoza‐Contreras, J. G., Estrada‐Cardona, A., Farrell, J., Farsi, A., Ferrero, J., Fokkens, W. J., Fonseca, J., Fontaine, J. F., Forti, S., Gálvez‐Romero, J. L., García‐Cobas, C. I., Garcia Cruz, M. H., Gemicioğlu, B., Gerth van Wijk, R., Guidacci, M., Gómez‐Vera, J., Guldemond, N. A., Gutter, Z., Haahtela, T., Hajjam, J., Hellings, P. W., Hernández‐Velázquez, L., Illario, M., Ivancevich, J. C., Jares, E., Joos, G., Just, J., Kalayci, O., Kalyoncu, A. F., Karjalainen, J., Keil, T., Khaltaev, N., Klimek, L., Kritikos, V., Kull, I., Kuna, P., Kvedariene, V., Kolek, V., Krzych‐Fałta, E., Kupczyk, M., Lacwik, P., La Grutta, S., Larenas‐Linnemann, D., Laune, D., Lauri, D., Lavrut, J., Lessa, M., Levato, G., Lewis, L., Lieten, I., Lipiec, A., Louis, R., Luna‐Pech, J. A., Magnan, A., Malva, J., Maspero, J. F., Matta‐Campos, J. J., Mayora, O., Medina‐Ávalos, M. A., Melén, E., Menditto, E., Millot‐Keurinck, J., Moda, G., Morais‐Almeida, M., Mösges, R., Mota‐Pinto, A., Mullol, J., Muraro, A., Murray, R., Noguès, M., Nalin, M., Napoli, L., Neffen, H., OʼHehir, R. E., Onorato, G. L., Palkonen, S., Papadopoulos, N. G., Passalacqua, G., Pépin, J. L., Pereira, A. M., Persico, M., Pfaar, O., Pozzi, A. C., Prokopakis, E., Pugin, B., Raciborski, F., Rimmer, J., Rizzo, J. A., Robalo‐Cordeiro, C., Rodríguez‐González, M., Rolla, G., Roller‐Wirnsberger, R. E., Romano, A., Romano, M., Romano, M. R., Salimäki, J., Samolinski, B., Serpa, F. S., Shamai, S., Sierra, M., Sova, M., Sorlini, M., Stellato, C., Stelmach, R., Strandberg, T., Stroetmann, V., Stukas, R., Szylling, A., Tan, R., Tibaldi, V., Todo‐Bom, A., Toppila‐Salmi, S., Tomazic, P., Trama, U., Triggiani, M., Valero, A., Valovirta, E., Valiulis, A., van Eerd, M., Vasankari, T., Vatrella, A., Ventura, M. T., Verissimo, M. T., Viart, F., Williams, S., Wagenmann, M., Wanscher, C., Westman, M., Wickman, M., Young, I., Yorgancioglu, A., Zernotti, E., Zuberbier, T., Zurkuhlen, A., De Oliviera, B., and Senn, A.

Published
2018
Full Text
View/download PDF

3. Validation of the MASK‐rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

Author

Caimmi, D., Baiz, N., Tanno, L. K., Demoly, P., Arnavielhe, S., Murray, R., Bedbrook, A., Bergmann, K. C., De Vries, G., Fokkens, W. J., Fonseca, J., Haahtela, T., Keil, T., Kuna, P., Mullol, J., Papadopoulos, N., Passalacqua, G., Samolinski, B., Tomazic, P. V., Valiulis, A., van Eerd, M., Wickman, M., Annesi‐Maesano, I., Bousquet, J., Agache, I, Angles, R, Anto, JM, Asayag, E, Bacci, E, Bachert, C, Baroni, I, Barreto, BA, Bedolla‐Barajas, M, Bertorello, L, Bewick, M, Bieber, T, Birov, S, Bindslev‐Jensen, C, Blua, A, Bochenska Marciniak, M, Bogus‐Buczynska, I, Bosnic‐Ancevich, S, Bosse, I, Bourret, R, Bucca, C, Buonaiuto, R, Caiazza, D, Caillot, D, Caimmi, DP, Camargos, P, Canfora, G, Cardona, V, Carriazo, AM, Cartier, C, Castellano, G, Chavannes, NH, Ciaravolo, MM, Cingi, C, Ciceran, A, Colas, L, Colgan, E, Coll, J, Conforti, D, Correira de Sousa, J, Cortés‐Grimaldo, RM, Corti, F, Costa, E, Courbis, AL, Cruz, A, Custovic, A, Dario, C, da Silva, M, Dauvilliers, Y, De Blay, F, Dedeu, T, De Feo, G, De Martino, B, Di Capua, S, Di Carluccio, N, Dray, G, Dubakiene, R, Eller, E, Emuzyte, R, Espinoza‐Contreras, JM, Estrada‐Cardona, A, Farrell, J, Ferrero, J, Fontaine, JF, Forti, S, Gálvez‐Romero, JL, Garcia Cruz, MH, García‐Cobas, CI, Gemicioğlu, B, Gerth van Wijck, R, Guidacci, M, Gómez‐Vera, J, Guldemond, NA, Gutter, Z, Hajjam, J, Hellings, P, Hernández‐Velázquez, L, Illario, M, Ivancevich, JC, Jares, E, Joos, G, Just, J, Kalayci, O, Kalyoncu, AF, Karjalainen, J, Khaltaev, N, Klimek, L, Kull, I, Kuna, TP, Kvedariene, V, Kolek, V, Krzych‐Fałta, E, Kupczyk, M, Lacwik, P, Larenas‐Linnemann, D, Laune, D, Lauri, D, Lavrut, J, Lessa, M, Levato, G, Lewis, L, Lieten, I, Lipiec, A, Louis, R, Luna‐Pech, JA, Magnan, A, Malva, J, Maspero, JF, Mayora, O, Medina‐Ávalos, MA, Melen, E, Menditto, E, Millot‐Keurinck, J, Moda, G, Morais‐Almeida, M, Mösges, R, Mota‐Pinto, A, Muraro, A, Noguès, M, Nalin, M, Napoli, L, Neffen, H, OʼHehir, R, Olivé Elias, M, Onorato, G, Palkonen, S, Pépin, JL, Pereira, AM, Persico, M, Pfaar, O, Pozzi, AC, Prokopakis, EP, Raciborski, F, Rizzo, JA, Robalo‐Cordeiro, C, Rodríguez‐González, M, Rolla, G, Roller‐Wirnsberger, RE, Romano, A, Romano, M, Salimäki, J, Serpa, FS, Shamai, S, Sierra, M, Sova, M, Sorlini, M, Stellato, C, Stelmach, R, Strandberg, T, Stroetman, V, Stukas, R, Szylling, A, Tibaldi, V, Todo‐Bom, A, Toppila‐Salmi, S, Tomazic, P, Trama, U, Triggiani, M, Valero, A, Valovirta, E, van Eerd, M, Vasankari, T, Vatrella, A, Ventura, MT, Verissimo, MT, Viart, F, Williams, S, Wagenmann, M, Wanscher, C, Westman, M, Young, I, Yorgancioglu, A, Zernotti, E, Zurbierber, T, Zurkuhlen, A, De Oliviera, B, and Senn, A

Published
2017
Full Text
View/download PDF

4. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

Author

Bousquet, J. Agache, I. Aliberti, M.R. Angles, R. Annesi-Maesano, I. Anto, J.M. Arnavielhe, S. Asayag, E. Bacci, E. Bedbrook, A. Bachert, C. Baroni, I. Barreto, B.A. Bedolla-Barajas, M. Bergmann, K.C. Bertorello, L. Bewick, M. Bieber, T. Birov, S. Bindslev-Jensen, C. Blua, A. Bochenska Marciniak, M. Bogus-Buczynska, I. Bosnic-Anticevich, S. Bosse, I. Bourret, R. Bucca, C. Buonaiuto, R. Burguete Cabanas, M.T. Caillaud, D. Caimmi, D.P. Caiazza, D. Camargos, P. Canfora, G. Cardona, V. Carriazo, A.M. Cartier, C. Castellano, G. Chavannes, N.H. Cecci, L. Ciaravolo, M.M. Cingi, C. Ciceran, A. Colas, L. Colgan, E. Coll, J. Conforti, D. Correia de Sousa, J. Cortés-Grimaldo, R.M. Corti, F. Costa, E. Courbis, A.L. Cousein, E. Cruz, A.A. Custovic, A. Cvetkovski, B. Dario, C. da Silva, J. Dauvilliers, Y. De Blay, F. Dedeu, T. De Feo, G. De Martino, B. Demoly, P. De Vries, G. Di Capua Ercolano, S. Di Carluccio, N. Doulapsi, M. Dray, G. Dubakiene, R. Eller, E. Emuzyte, R. Espinoza-Contreras, J.G. Estrada-Cardona, A. Farrell, J. Farsi, A. Ferrero, J. Fokkens, W.J. Fonseca, J. Fontaine, J.F. Forti, S. Gálvez-Romero, J.L. García-Cobas, C.I. Garcia Cruz, M.H. Gemicioğlu, B. Gerth van Wijk, R. Guidacci, M. Gómez-Vera, J. Guldemond, N.A. Gutter, Z. Haahtela, T. Hajjam, J. Hellings, P.W. Hernández-Velázquez, L. Illario, M. Ivancevich, J.C. Jares, E. Joos, G. Just, J. Kalayci, O. Kalyoncu, A.F. Karjalainen, J. Keil, T. Khaltaev, N. Klimek, L. Kritikos, V. Kull, I. Kuna, P. Kvedariene, V. Kolek, V. Krzych-Fałta, E. Kupczyk, M. Lacwik, P. La Grutta, S. Larenas-Linnemann, D. Laune, D. Lauri, D. Lavrut, J. Lessa, M. Levato, G. Lewis, L. Lieten, I. Lipiec, A. Louis, R. Luna-Pech, J.A. Magnan, A. Malva, J. Maspero, J.F. Matta-Campos, J.J. Mayora, O. Medina-Ávalos, M.A. Melén, E. Menditto, E. Millot-Keurinck, J. Moda, G. Morais-Almeida, M. Mösges, R. Mota-Pinto, A. Mullol, J. Muraro, A. Murray, R. Noguès, M. Nalin, M. Napoli, L. Neffen, H. O'Hehir, R.E. Onorato, G.L. Palkonen, S. Papadopoulos, N.G. Passalacqua, G. Pépin, J.L. Pereira, A.M. Persico, M. Pfaar, O. Pozzi, A.C. Prokopakis, E. Pugin, B. Raciborski, F. Rimmer, J. Rizzo, J.A. Robalo-Cordeiro, C. Rodríguez-González, M. Rolla, G. Roller-Wirnsberger, R.E. Romano, A. Romano, M. Romano, M.R. Salimäki, J. Samolinski, B. Serpa, F.S. Shamai, S. Sierra, M. Sova, M. Sorlini, M. Stellato, C. Stelmach, R. Strandberg, T. Stroetmann, V. Stukas, R. Szylling, A. Tan, R. Tibaldi, V. Todo-Bom, A. Toppila-Salmi, S. Tomazic, P. Trama, U. Triggiani, M. Valero, A. Valovirta, E. Valiulis, A. van Eerd, M. Vasankari, T. Vatrella, A. Ventura, M.T. Verissimo, M.T. Viart, F. Williams, S. Wagenmann, M. Wanscher, C. Westman, M. Wickman, M. Young, I. Yorgancioglu, A. Zernotti, E. Zuberbier, T. Zurkuhlen, A. De Oliviera, B. Senn, A.

Subjects
humanities
Abstract

The overarching goals of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) are to enable European citizens to lead healthy, active and independent lives whilst ageing. The EIP on AHA includes 74 Reference Sites. The aim of this study was to transfer innovation from an app developed by the MACVIA-France EIP on AHA reference site (Allergy Diary) to other reference sites. The phenotypic characteristics of rhinitis and asthma multimorbidity in adults and the elderly will be compared using validated information and communication technology (ICT) tools (i.e. the Allergy Diary and CARAT: Control of Allergic Rhinitis and Asthma Test) in 22 Reference Sites or regions across Europe. This will improve the understanding, assessment of burden, diagnosis and management of rhinitis in the elderly by comparison with an adult population. Specific objectives will be: (i) to assess the percentage of adults and elderly who are able to use the Allergy Diary, (ii) to study the phenotypic characteristics and treatment over a 1-year period of rhinitis and asthma multimorbidity at baseline (cross-sectional study) and (iii) to follow-up using visual analogue scale (VAS). This part of the study may provide some insight into the differences between the elderly and adults in terms of response to treatment and practice. Finally (iv) work productivity will be examined in adults. © 2017 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Published
2018

5. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

Author

Bousquet, J. and Agache, I. and Aliberti, M.R. and Angles, R. and Annesi-Maesano, I. and Anto, J.M. and Arnavielhe, S. and Asayag, E. and Bacci, E. and Bedbrook, A. and Bachert, C. and Baroni, I. and Barreto, B.A. and Bedolla-Barajas, M. and Bergmann, K.C. and Bertorello, L. and Bewick, M. and Bieber, T. and Birov, S. and Bindslev-Jensen, C. and Blua, A. and Bochenska Marciniak, M. and Bogus-Buczynska, I. and Bosnic-Anticevich, S. and Bosse, I. and Bourret, R. and Bucca, C. and Buonaiuto, R. and Burguete Cabanas, M.T. and Caillaud, D. and Caimmi, D.P. and Caiazza, D. and Camargos, P. and Canfora, G. and Cardona, V. and Carriazo, A.M. and Cartier, C. and Castellano, G. and Chavannes, N.H. and Cecci, L. and Ciaravolo, M.M. and Cingi, C. and Ciceran, A. and Colas, L. and Colgan, E. and Coll, J. and Conforti, D. and Correia de Sousa, J. and Cortés-Grimaldo, R.M. and Corti, F. and Costa, E. and Courbis, A.L. and Cousein, E. and Cruz, A.A. and Custovic, A. and Cvetkovski, B. and Dario, C. and da Silva, J. and Dauvilliers, Y. and De Blay, F. and Dedeu, T. and De Feo, G. and De Martino, B. and Demoly, P. and De Vries, G. and Di Capua Ercolano, S. and Di Carluccio, N. and Doulapsi, M. and Dray, G. and Dubakiene, R. and Eller, E. and Emuzyte, R. and Espinoza-Contreras, J.G. and Estrada-Cardona, A. and Farrell, J. and Farsi, A. and Ferrero, J. and Fokkens, W.J. and Fonseca, J. and Fontaine, J.F. and Forti, S. and Gálvez-Romero, J.L. and García-Cobas, C.I. and Garcia Cruz, M.H. and Gemicioğlu, B. and Gerth van Wijk, R. and Guidacci, M. and Gómez-Vera, J. and Guldemond, N.A. and Gutter, Z. and Haahtela, T. and Hajjam, J. and Hellings, P.W. and Hernández-Velázquez, L. and Illario, M. and Ivancevich, J.C. and Jares, E. and Joos, G. and Just, J. and Kalayci, O. and Kalyoncu, A.F. and Karjalainen, J. and Keil, T. and Khaltaev, N. and Klimek, L. and Kritikos, V. and Kull, I. and Kuna, P. and Kvedariene, V. and Kolek, V. and Krzych-Fałta, E. and Kupczyk, M. and Lacwik, P. and La Grutta, S. and Larenas-Linnemann, D. and Laune, D. and Lauri, D. and Lavrut, J. and Lessa, M. and Levato, G. and Lewis, L. and Lieten, I. and Lipiec, A. and Louis, R. and Luna-Pech, J.A. and Magnan, A. and Malva, J. and Maspero, J.F. and Matta-Campos, J.J. and Mayora, O. and Medina-Ávalos, M.A. and Melén, E. and Menditto, E. and Millot-Keurinck, J. and Moda, G. and Morais-Almeida, M. and Mösges, R. and Mota-Pinto, A. and Mullol, J. and Muraro, A. and Murray, R. and Noguès, M. and Nalin, M. and Napoli, L. and Neffen, H. and O'Hehir, R.E. and Onorato, G.L. and Palkonen, S. and Papadopoulos, N.G. and Passalacqua, G. and Pépin, J.L. and Pereira, A.M. and Persico, M. and Pfaar, O. and Pozzi, A.C. and Prokopakis, E. and Pugin, B. and Raciborski, F. and Rimmer, J. and Rizzo, J.A. and Robalo-Cordeiro, C. and Rodríguez-González, M. and Rolla, G. and Roller-Wirnsberger, R.E. and Romano, A. and Romano, M. and Romano, M.R. and Salimäki, J. and Samolinski, B. and Serpa, F.S. and Shamai, S. and Sierra, M. and Sova, M. and Sorlini, M. and Stellato, C. and Stelmach, R. and Strandberg, T. and Stroetmann, V. and Stukas, R. and Szylling, A. and Tan, R. and Tibaldi, V. and Todo-Bom, A. and Toppila-Salmi, S. and Tomazic, P. and Trama, U. and Triggiani, M. and Valero, A. and Valovirta, E. and Valiulis, A. and van Eerd, M. and Vasankari, T. and Vatrella, A. and Ventura, M.T. and Verissimo, M.T. and Viart, F. and Williams, S. and Wagenmann, M. and Wanscher, C. and Westman, M. and Wickman, M. and Young, I. and Yorgancioglu, A. and Zernotti, E. and Zuberbier, T. and Zurkuhlen, A. and De Oliviera, B. and Senn, A., MACVIA-France, Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France, VIMA, INSERM U 1168, VIMA: Ageing and Chronic Diseases, Epidemiological and Public Health Approaches, Villejuif, France, Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France, Faculty of Medicine, Transylvania University, Brasov, Romania, Municipality of Salerno, Salerno, Italy, Innovación y nuevas tecnologías, Salud Sector sanitario de Barbastro, Barbastro, Spain, EPAR U707 INSERM, Paris, France, EPAR UMR-S UPMC, Paris VI, Paris, France, ISGLoBAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain, IMIM (Hospital del Mar Research Institute), Universitat Pompeu Fabra (UPF), Barcelona, Spain, CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Pompeu Fabra (UPF), Barcelona, Spain, Kyomed, Montpellier, France, Argentine Society of Allergy and Immunopathology, Buenos Aires, Argentina, Regione Liguria, Genoa, Italy, Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium, Telbios SRL, Milan, Italy, Alergologo, Belem, Brazil, Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalarara, Mexico, Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany, Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany, iQ4U Consultants Ltd, London, United Kingdom, Department of Dermatology and Allergy, Rheinische Friedrich-Wilhelms-University, Bonn, Germany, Empirica Communication and Technology Research, Bonn, Germany, Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark, Argentine Association of Respiratory Medicine, Buenos Aires, Argentina, Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland, Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW, Australia, Allergist, La Rochelle, France, Centre Hospitalier Valenciennes, Valenciennes, France, Chief of the University Pneumology Unit- AOU Molinette, Hospital City of Health and Science of Torino, Torino, Italy, Pharmacist of COFASER - Consorzio Farmacie Servizi-Salerno, Salerno, Italy, Centro Médico Zambrano Hellion, Monterrey, Mexico, Gesundheitsregion KölnBonn - HRCB Projekt GmbH, Kohln, Germany, Service de pneumologie, CHU et université d'Auvergne, Clermont-Ferrand, France, Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France, Department of Pediatrics, Medical School, Federal University of Minas Gerais, Belo Horizonte, Brazil, Mayor of Sarno and President of Salerno Province, Anesthesiology Service, Sarno 'Martiri del Villa Malta' Hospital, Sarno, Italy, S. Allergologia, S. Medicina Interna, Hospital Vall d'Hebron, Barcelona, Spain, Regional Ministry of Health of Andalusia, Seville, Spain, ASA - Advanced Solutions Accelerator, Clapiers, France, Celentano Pharmacy, Massa Lubrense, Italy, Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands, S.O.S Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy, Specialist Social Worker, Sorrento, Italy, ENT Department, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey, Argentine Federation of Otorhinolaryngology Societies, Buenos Aires, Argentina, Service de Pneumologie, UMR INSERM, UMR1087and CNR 6291, l'institut du thorax, University of Nantes, Nantes, France, Department of Health, Social Services and Public Safety, Belfast, United Kingdom, Fondazione Bruno Kessler (FBK), Trento, Italy, Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal, Alergologa, Guadalarara, Mexico, FIMMG (Federazione Italiana Medici di Medicina Generale), Milan, Italy, UCIBIO, REQYULTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (AgeUPNetWork), Porto, Portugal, Ecole des Mines, Alès, France, Vice Président de la CME - Centre Hospitalier, Valenciennes, France, ProAR – Nucleo de Excelencia em Asma, Federal University of Bahia, Bahia, Brazil, GARD/WHO Executive Committee and Federal University of Bahia, Bahia, Brazil, Department of Pediatric, Imperial College London, London, United Kingdom, Azienda Provinciale per i Servizi Sanitari di Trento (APSS-Trento), Trento, Italy, Allergy Service, University Hospital of Federal University of Santa Catarina (HU-UFSC), Florianópolis, Brazil, Sleep Unit, Department of Neurology, Hôpital Gui-de-Chauliac Montpellier, Inserm U1061, Montpellier, France, Allergy Division, Chest Disease Department, University Hospital of Strasbourg, Strasbourg, France, AQuAS, Barcelona, Spain & EUREGHA, European Regional and Local Health Association, Brussels, Belgium, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Salerno, Italy, Social Workers Coordinator, Sorrento, Italy, Peercode DV, Gerdermalsen, Netherlands, Farmacie Dei Golfi Group, Massa Lubrense, Italy, Department of Otolaryngology, University of Crete School of Medicine, Heraklion, Greece, Medical Faculty, Vilnius University, Vilnius, Lithuania, Clinic of Children's Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania, University of Aguascalientes, Chihuaha, Mexico, Alergologo, Playa del Carmen, Mexico, Andalusian Agency for Healthcare Quality, Seville, Spain, Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, Netherlands, Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal, Allergy Unit, CUF Porto Instituto & Hospital, Porto, Portugal, Allergist, Reims, France, Regional Hospital of ISSSTE, Puebla, Mexico, Alergologo, Guadalarara, Mexico, Allergy Clinic, National Institute of Respiratory Diseases, Mexico City, Mexico, Department of Pulmonary Diseases, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey, Department of Internal Medicine, Section of Allergology, Erasmus MC, Rotterdam, Netherlands, Member of the Brazilian Society of Pediatrics and Society of Immunization, Representative of GINA (Global Initiative Against Asthma), Brasilia, Brazil, Allergy Clinic, Hospital Regional del ISSSTE ‘Lic. López Mateos’, Mexico City, Mexico, Institute of Health Policy and Management iBMG, Erasmus University, Rotterdam, Netherlands, University Hospital Olomouc – National eHealth Centre, Olomouk, Czech Republic, Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland, Centich: centre d'expertise national des technologies de l'information et de la communication pour l'autonomie, Gérontopôle autonomie longévité des Pays de la Loire, Conseil régional des Pays de la Loire, Centre d'expertise Partenariat Européen d'Innovation pour un vieillissement actif et en bonne santé, Nantes, France, Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium, Alergologo, Ensenada, Mexico, Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy, Servicio de Alergia e Immunologia, Clinica Santa Isabel, Buenos Aires, Argentina, Libra Foundation, Buenos Aires, Argentina, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium, Allergology Department, Centre de l'Asthme et des Allergies, Hôpital d'Enfants Armand-Trousseau (APHP, Paris), Paris, France, Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe EPAR, Paris, France, Pediatric Allergy and Asthma Unit, Hacettepe University School of Medicine, Ankara, Turkey, Immunology and Allergy Division, Department of Chest Diseases, School of Medicine, Hacettepe University, Ankara, Turkey, Allergy Centre, Tampere University Hospital, Tampere, Finland, Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, and Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany, GARD, Geneva, Switzerland, Center for Rhinology and Allergology, Wiesbaden, Germany, Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden, Clinic of Infectious, Chest Diseases, Dermatology and Allergology, Vilnius University, Vilnius, Lithuania, Department of Respiratory Medicine, Faculty of Medicine and Dentistry, University Hospital, Olomouc, Czech Republic, Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland, Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, Clínica de Alergia, Asma y Pediatría, Hospital Médica Sur, México City, Mexico, Presidente CMMC, Milano, Italy, Head of the Allergy Department of Pedro de Elizalde Children's Hospital, Buenos Aires, Argentina, Faculdade de Medicina da Universidade Federal da Bahia, Salvador de Bahia, Brazil, Sifmed, Milano, Italy, Promotor B3 Action GRoup EIP on AHA and Senior Fellow, International Foundation for Integreted Care, Aberystwyth, United Kingdom, Tech Life Valley, Diepenbeek, Belgium, Department of Pulmonary Medicine, CHU Sart-Tilman, Liege, Belgium, University of Guadalajara, Guadalara, Mexico, Faculty of Medicine, Institute of Biomedical Imaging and Life Sciences (IBILI), University of Coimbra, Coimbra, Portugal, Ageing@Coimbra EIP-AHA Reference Site, Coimbra, Portugal, Argentine Association of Allergy and Clinical Immunology, Buenos Aires, Argentina, Hospital Regional Siglo XXI, Mexico City, Mexico, Alergologo, Veracruz, Mexico, Sachs’ Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, CIRFF, Federico II University, Naples, Italy, Caisse d'assurance retraite et de la santé au travail du Languedoc-Roussillon (CARSAT-LR), Montpellier, France, Regione Piemonte, Torino, Italy, Allergy and Clinical Immunology Department, Hospital CUF-Descobertas, Lisboa, Portugal, Institute of Medical Statistics, Informatics and Epidemiology, Medical Faculty, University of Cologne, Cologne, Germany, Laboratory of General Pathology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal, Institute of Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal, Clinical & Experimental Respiratory Immunoallergy, ENT Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain, Department of Women and Child Health, Food Allergy Referral Centre Veneto Region, Padua General University Hospital, Padua, Italy, MedScript Ltd, Dundalk, Co. Louth, Ireland, Consortium of Pharmacies and Services COSAFER, Salerno, Italy, Head of Respiratory Medicine, Alassia Children's Hospital, Center for Allergy and Immunology, Santa Fe, Argentina, Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia, EFA European Federation of Allergy and Airways Diseases Patients’ Associations, Brussels, Belgium, Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, Manchester, United Kingdom, Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital 'P&A Kyriakou', University of Athens, Athens, Greece, Allergy and Respiratory Diseases, IRCCS San Martino Hospital-IST-University of Genoa, Genoa, Italy, Department of Pneumology, CHU Grenoble, Grenoble, France, Allergy Unit, CUF-Porto Hospital and Institute, Center for Research in Health Technologies and Information Systems, CINTESIS, Universidade do Porto, Porto, Portugal, Sociologist, Municipality, Sorrento, Italy, Vice-Presidente of IML, Milano, Italy, Alergista, Recife, Brazil, Centre of Pneumology, Coimbra University Hospital, Coimbra, Portugal, Alergologo, Mexico City, Mexico, Medical University of Graz, Graz, Austria, Allergy Unit, Presidio Columbus, Rome, Catholic University of Sacred Heart, Rome, Italy, IRCCS Oasi Maria S.S., Troina, Italy, Association of Finnish Pharmacists, Helsinki, Finland, Allergist, Vitoria, Brazil, Departement of Internal Medicine, University Hospital, Olomouc, Czech Republic, IML (Lombardy Medical Initiative), Bergamo, Italy, Pulmonary Division, Heart Institute (InCor), Hospital da Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil, Center for Life Course Health Research, Helsinki University Hospital, Helsinki University, University of Oulu, Oulu, Finland, Public Health Institute of Vilnius University, Vilnius, Lithuania, Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal, Department of ENT, Medical University of Graz, Graz, Austria, Division on Pharmacy and Devices Policy, Campania Region, Naples, Italy, Pneumology and Allergy Department, Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain, Department of Lung Diseases and Clinical Allergology, University of Turku, Turku, Finland, Allergy Clinic, Terveystalo, Turku, Finland, Vilnius University Clinic of Children's Diseases and Public Health Institute, Vilnius, Lithuania, European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium, FILHA, Finnish Lung Association, Helsinki, Finland, Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy, International Primary Care Respiratory Group IPCRG, Aberdeen, United Kingdom, Department of Otorhinolaryngology, HNO-Klinik, Universitätsklinikum Düsseldorf, Düsseldorf, Germany, EIP on AHA Coordinator, Region of Southern Denmark, Odense, Denmark, Department of Medicine Solna, Immunology and Allergy Unit, Karolinska Institutet and Department of ENT Diseases, Karolinska University Hospital, Stockholm, Sweden, Queen's University, Belfast, United Kingdom, Celal Bayar University Department of Pulmonology, GARD Executive Committee, Manisa, Turkey, Universidad Católica de Córdoba, Córdoba, Argentina, and EC-CNECT-H2, European Commission, Brussels, Belgium

Subjects
humanities
Abstract

The overarching goals of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) are to enable European citizens to lead healthy, active and independent lives whilst ageing. The EIP on AHA includes 74 Reference Sites. The aim of this study was to transfer innovation from an app developed by the MACVIA-France EIP on AHA reference site (Allergy Diary) to other reference sites. The phenotypic characteristics of rhinitis and asthma multimorbidity in adults and the elderly will be compared using validated information and communication technology (ICT) tools (i.e. the Allergy Diary and CARAT: Control of Allergic Rhinitis and Asthma Test) in 22 Reference Sites or regions across Europe. This will improve the understanding, assessment of burden, diagnosis and management of rhinitis in the elderly by comparison with an adult population. Specific objectives will be: (i) to assess the percentage of adults and elderly who are able to use the Allergy Diary, (ii) to study the phenotypic characteristics and treatment over a 1-year period of rhinitis and asthma multimorbidity at baseline (cross-sectional study) and (iii) to follow-up using visual analogue scale (VAS). This part of the study may provide some insight into the differences between the elderly and adults in terms of response to treatment and practice. Finally (iv) work productivity will be examined in adults. © 2017 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Published
2018

6. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - Reference Site Twinning (EIP on AHA)

Author

Bousquet, J, Agache, I, Aliberti, MR, Angles, R, Annesi-Maesano, I, Anto, JM, Arnavielhe, S, Asayag, E, Bacci, E, Bedbrook, A, Bachert, C, Valero, A, Valovirta, E, Valiulis, A, Van Eerd, M, Vasankari, T, Vatrella, A, Ventura, MT, Verissimo, MT, Viart, F, Bindslev-Jensen, C, Khaltaev, N, Williams, S, Wagenmann, M, Wanscher, C, Westman, M, Wickman, M, Young, I, Yorgancioglu, A, Zernotti, E, Zurbierber, T, Zurkuhlen, A, Klimek, L, Blua, A, De Oliviera, B, Senn, A, Bochenska Marciniak, M, Bogus-Buczynska, I, Bosnic-Anticevich, S, Bosse, I, Bourret, R, Bucca, C, Buonaiuto, R, Kritikos, V, Caiazza, D, Caillot, D, Caimmi, DP, Camargos, P, Canfora, G, Cardona, V, Carriazo, AM, Cartier, C, Castellano, G, Chavannes, NH, Kull, I, Ciaravolo, MM, Cingi, C, Ciceran, A, Colas, L, Colgan, E, Coll, J, Conforti, D, De Sousa, JC, Cortés-Grimaldo, RM, Corti, F, Kuna, P, Costa, E, Courbis, AL, Cousein, E, Cruz, AA, Custovic, A, Cvetkovski, B, Dario, C, Da Silva, M, Dauvilliers, Y, De Blay, F, Kvedariene, V, Dedeu, T, De Feo, G, De Martino, B, Demoly, P, De Vries, G, Di Capua Ercolano, S, Di Carluccio, N, Doulapsi, M, Dray, G, Dubakiene, R, Kolek, V, Eller, E, Emuzyte, R, Espinoza-Contreras, JM, Estrada-Cardona, A, Farrell, J, Ferrero, J, Fokkens, WJ, Fonseca, J, Fontaine, JF, Forti, S, Krzych-Fałta, E, Gálvez-Romero, JL, García-Cobas, CI, Cruz, MHG, Gemicioğlu, B, Van Wijk, RG, Guidacci, M, Gómez-Vera, J, Guldemond, NA, Gutter, Z, Haahtela, T, Kupczyk, M, Hajjam, J, Hellings, PW, Hernández-Velázquez, L, Illario, M, Ivancevich, JC, Jares, E, Joos, G, Just, J, Kalayci, O, Kalyoncu, AF, Lacwik, P, Karjalainen, J, Keil, T, Baroni, I, Larenas-Linnemann, D, Laune, D, Lauri, D, Lavrut, J, Lessa, M, Levato, G, Lewis, L, Lieten, I, Lipiec, A, Louis, R, Barreto, BA, Luna-Pech, JA, Magnan, A, Malva, J, Maspero, JF, Matta-Campos, JJ, Mayora, O, Medina-Ávalos, MA, Melén, E, Menditto, E, Millot-Keurinck, J, Bedolla-Barajas, M, Moda, G, Morais-Almeida, M, Mösges, R, Mota-Pinto, A, Mullol, J, Muraro, A, Murray, R, Noguès, M, Nalin, M, Napoli, L, Bergmann, KC, Neffen, H, O'Hehir, RE, Onorato, G, Palkonen, S, Papadopoulos, NG, Passalacqua, G, Pépin, JL, Pereira, AM, Persico, M, Pfaar, O, Bertorello, L, Pozzi, AC, Prokopakis, E, Raciborski, F, Rimmer, J, Rizzo, JA, Robalo-Cordeiro, C, Rodríguez-González, M, Rolla, G, Roller-Wirnsberger, RE, Romano, A, Bewick, M, Romano, M, Salimäki, J, Samolinski, B, Serpa, FS, Shamai, S, Sierra, M, Sova, M, Sorlini, M, Stellato, C, Stelmach, R, Bieber, T, Strandberg, T, Stroetmann, V, Stukas, R, Szylling, A, Tan, R, Tibaldi, V, Todo-Bom, A, Toppila-Salmi, S, Tomazic, P, Trama, U, Birov, S, and Triggiani, M

Subjects
HEALTH-STATUS, Science & Technology, Allergy Diary, Allergy, CARAT, IMPACT, Immunology, CARE PATHWAYS, QUESTIONNAIRE, asthma, PARTNERSHIP, WORK PRODUCTIVITY, VALIDATION, European Innovation Partnership on Active and Healthy Ageing, rhinitis, QUALITY-OF-LIFE, 1107 Immunology, MASK-RHINITIS, Life Sciences & Biomedicine, EUROPEAN COUNTRIES
Abstract

The overarching goals of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) are to enable European citizens to lead healthy, active and independent lives while ageing. The EIP on AHA includes 74 Reference Sites. The aim of this study is to transfer innovation from an App developed by the MACVIA-France EIP on AHA reference site (Allergy Diary) to other reference sites. The phenotypic characteristics of rhinitis and asthma multimorbidity in adults and the elderly will be compared using validated information and communication technology (ICT) tools (i.e. the Allergy Diary and CARAT: Control of Allergic Rhinitis and Asthma Test) in 22 Reference Sites or regions across Europe. This will improve understanding, assessment of burden, diagnosis and management of rhinitis in the elderly by comparison with an adult population. Specific objectives will: (i) assess the percentage of adults and elderly who are able to use the Allergy Diary, (ii) study phenotypic characteristics and treatment over a period of one year of rhinitis and asthma multimorbidity at baseline (cross-sectional study) and (iii) follow-up using visual analogue scale (VAS). This part of the study may provide some insight into the differences between the elderly and adults in terms of response to treatment and practice. Finally (iv) work productivity will be examined in adults. This article is protected by copyright. All rights reserved.

Published
2017

7. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

Author

Caimmi, D. Baiz, N. Tanno, L.K. Demoly, P. Arnavielhe, S. Murray, R. Bedbrook, A. Bergmann, K.C. De Vries, G. Fokkens, W.J. Fonseca, J. Haahtela, T. Keil, T. Kuna, P. Mullol, J. Papadopoulos, N. Passalacqua, G. Samolinski, B. Tomazic, P.V. Valiulis, A. van Eerd, M. Wickman, M. Annesi-Maesano, I. Bousquet, J. the MASK Study Group Agache, I. Angles, R. Anto, J.M. Asayag, E. Bacci, E. Bachert, C. Baroni, I. Barreto, B.A. Bedolla-Barajas, M. Bertorello, L. Bewick, M. Bieber, T. Birov, S. Bindslev-Jensen, C. Blua, A. Bochenska Marciniak, M. Bogus-Buczynska, I. Bosnic-Ancevich, S. Bosse, I. Bourret, R. Bucca, C. Buonaiuto, R. Caiazza, D. Caillot, D. Caimmi, D.P. Camargos, P. Canfora, G. Cardona, V. Carriazo, A.M. Cartier, C. Castellano, G. Chavannes, N.H. Ciaravolo, M.M. Cingi, C. Ciceran, A. Colas, L. Colgan, E. Coll, J. Conforti, D. Correira de Sousa, J. Cortés-Grimaldo, R.M. Corti, F. Costa, E. Courbis, A.L. Cruz, A. Custovic, A. Dario, C. da Silva, M. Dauvilliers, Y. De Blay, F. Dedeu, T. De Feo, G. De Martino, B. Di Capua, S. Di Carluccio, N. Dray, G. Dubakiene, R. Eller, E. Emuzyte, R. Espinoza-Contreras, J.M. Estrada-Cardona, A. Farrell, J. Ferrero, J. Fontaine, J.F. Forti, S. Gálvez-Romero, J.L. Garcia Cruz, M.H. García-Cobas, C.I. Gemicioğlu, B. Gerth van Wijck, R. Guidacci, M. Gómez-Vera, J. Guldemond, N.A. Gutter, Z. Hajjam, J. Hellings, P. Hernández-Velázquez, L. Illario, M. Ivancevich, J.C. Jares, E. Joos, G. Just, J. Kalayci, O. Kalyoncu, A.F. Karjalainen, J. Khaltaev, N. Klimek, L. Kull, I. Kuna, T.P. Kvedariene, V. Kolek, V. Krzych-Fałta, E. Kupczyk, M. Lacwik, P. Larenas-Linnemann, D. Laune, D. Lauri, D. Lavrut, J. Lessa, M. Levato, G. Lewis, L. Lieten, I. Lipiec, A. Louis, R. Luna-Pech, J.A. Magnan, A. Malva, J. Maspero, J.F. Mayora, O. Medina-Ávalos, M.A. Melen, E. Menditto, E. Millot-Keurinck, J. Moda, G. Morais-Almeida, M. Mösges, R. Mota-Pinto, A. Muraro, A. Noguès, M. Nalin, M. Napoli, L. Neffen, H. O'Hehir, R. Olivé Elias, M. Onorato, G. Palkonen, S. Pépin, J.L. Pereira, A.M. Persico, M. Pfaar, O. Pozzi, A.C. Prokopakis, E.P. Raciborski, F. Rizzo, J.A. Robalo-Cordeiro, C. Rodríguez-González, M. Rolla, G. Roller-Wirnsberger, R.E. Romano, A. Romano, M. Salimäki, J. Serpa, F.S. Shamai, S. Sierra, M. Sova, M. Sorlini, M. Stellato, C. Stelmach, R. Strandberg, T. Stroetman, V. Stukas, R. Szylling, A. Tibaldi, V. Todo-Bom, A. Toppila-Salmi, S. Tomazic, P. Trama, U. Triggiani, M. Valero, A. Valovirta, E. van Eerd, M. Vasankari, T. Vatrella, A. Ventura, M.T. Verissimo, M.T. Viart, F. Williams, S. Wagenmann, M. Wanscher, C. Westman, M. Young, I. Yorgancioglu, A. Zernotti, E. Zurbierber, T. Zurkuhlen, A. De Oliviera, B. Senn, A.

Abstract

Background: Visual Analogue Scale (VAS) is a validated tool to assess control in allergic rhinitis patients. Objective: The aim of this study was to validate the use of VAS in the MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) app (Allergy Diary) on smartphones screens to evaluate allergic rhinitis symptoms and disease control. Methods: Each user filled 4 different VAS measuring overall, nasal, ocular, and asthma symptoms at least once. Following COSMIN guidelines, we evaluated internal consistency, (Cronbach's alpha coefficient and test-retest), reliability (intraclass correlation coefficients), sensitivity, and acceptability of the MASK-Rhinitis VAS. Results: Between 1 August 2015 and 31 July 2016, the app was used 14 612 times in 15 countries. A total of 1225 users used it more than once, during the evaluated period. The tool resulted to be statistically satisfactory, showing excellent internal consistency (Cronbach's test > 0.84, test-retest > 0.7), reliability (>0.9), and acceptability. In addition, the tool had a good sensitivity when users (n = 521) answered the VAS twice in less than 3 hours. Conclusions and Clinical Relevance: The MASK-rhinitis VAS is a reliable and valid tool to assess allergic control on smartphone screens, at the population level. © 2017 John Wiley & Sons Ltd

Published
2017

9. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly ( MACVIA ‐ ARIA ) ‐ EIP on AHA Twinning Reference Site ( GARD research demonstration project)

Author

Bousquet, J., primary, Agache, I., additional, Aliberti, M. R., additional, Angles, R., additional, Annesi‐Maesano, I., additional, Anto, J. M., additional, Arnavielhe, S., additional, Asayag, E., additional, Bacci, E., additional, Bedbrook, A., additional, Bachert, C., additional, Baroni, I., additional, Barreto, B. A., additional, Bedolla‐Barajas, M., additional, Bergmann, K. C., additional, Bertorello, L., additional, Bewick, M., additional, Bieber, T., additional, Birov, S., additional, Bindslev‐Jensen, C., additional, Blua, A., additional, Bochenska Marciniak, M., additional, Bogus‐Buczynska, I., additional, Bosnic‐Anticevich, S., additional, Bosse, I., additional, Bourret, R., additional, Bucca, C., additional, Buonaiuto, R., additional, Burguete Cabanas, M. T., additional, Caillaud, D., additional, Caimmi, D. P., additional, Caiazza, D., additional, Camargos, P., additional, Canfora, G., additional, Cardona, V., additional, Carriazo, A. M., additional, Cartier, C., additional, Castellano, G., additional, Chavannes, N. H., additional, Cecci, L., additional, Ciaravolo, M. M., additional, Cingi, C., additional, Ciceran, A., additional, Colas, L., additional, Colgan, E., additional, Coll, J., additional, Conforti, D., additional, Correia de Sousa, J., additional, Cortés‐Grimaldo, R. M., additional, Corti, F., additional, Costa, E., additional, Courbis, A. L., additional, Cousein, E., additional, Cruz, A. A., additional, Custovic, A., additional, Cvetkovski, B., additional, Dario, C., additional, da Silva, J., additional, Dauvilliers, Y., additional, De Blay, F., additional, Dedeu, T., additional, De Feo, G., additional, De Martino, B., additional, Demoly, P., additional, De Vries, G., additional, Di Capua Ercolano, S., additional, Di Carluccio, N., additional, Doulapsi, M., additional, Dray, G., additional, Dubakiene, R., additional, Eller, E., additional, Emuzyte, R., additional, Espinoza‐Contreras, J. G., additional, Estrada‐Cardona, A., additional, Farrell, J., additional, Farsi, A., additional, Ferrero, J., additional, Fokkens, W. J., additional, Fonseca, J., additional, Fontaine, J. F., additional, Forti, S., additional, Gálvez‐Romero, J. L., additional, García‐Cobas, C. I., additional, Garcia Cruz, M. H., additional, Gemicioğlu, B., additional, Gerth van Wijk, R., additional, Guidacci, M., additional, Gómez‐Vera, J., additional, Guldemond, N. A., additional, Gutter, Z., additional, Haahtela, T., additional, Hajjam, J., additional, Hellings, P. W., additional, Hernández‐Velázquez, L., additional, Illario, M., additional, Ivancevich, J. C., additional, Jares, E., additional, Joos, G., additional, Just, J., additional, Kalayci, O., additional, Kalyoncu, A. F., additional, Karjalainen, J., additional, Keil, T., additional, Khaltaev, N., additional, Klimek, L., additional, Kritikos, V., additional, Kull, I., additional, Kuna, P., additional, Kvedariene, V., additional, Kolek, V., additional, Krzych‐Fałta, E., additional, Kupczyk, M., additional, Lacwik, P., additional, La Grutta, S., additional, Larenas‐Linnemann, D., additional, Laune, D., additional, Lauri, D., additional, Lavrut, J., additional, Lessa, M., additional, Levato, G., additional, Lewis, L., additional, Lieten, I., additional, Lipiec, A., additional, Louis, R., additional, Luna‐Pech, J. A., additional, Magnan, A., additional, Malva, J., additional, Maspero, J. F., additional, Matta‐Campos, J. J., additional, Mayora, O., additional, Medina‐Ávalos, M. A., additional, Melén, E., additional, Menditto, E., additional, Millot‐Keurinck, J., additional, Moda, G., additional, Morais‐Almeida, M., additional, Mösges, R., additional, Mota‐Pinto, A., additional, Mullol, J., additional, Muraro, A., additional, Murray, R., additional, Noguès, M., additional, Nalin, M., additional, Napoli, L., additional, Neffen, H., additional, O'Hehir, R. E., additional, Onorato, G. L., additional, Palkonen, S., additional, Papadopoulos, N. G., additional, Passalacqua, G., additional, Pépin, J. L., additional, Pereira, A. M., additional, Persico, M., additional, Pfaar, O., additional, Pozzi, A. C., additional, Prokopakis, E., additional, Pugin, B., additional, Raciborski, F., additional, Rimmer, J., additional, Rizzo, J. A., additional, Robalo‐Cordeiro, C., additional, Rodríguez‐González, M., additional, Rolla, G., additional, Roller‐Wirnsberger, R. E., additional, Romano, A., additional, Romano, M., additional, Romano, M. R., additional, Salimäki, J., additional, Samolinski, B., additional, Serpa, F. S., additional, Shamai, S., additional, Sierra, M., additional, Sova, M., additional, Sorlini, M., additional, Stellato, C., additional, Stelmach, R., additional, Strandberg, T., additional, Stroetmann, V., additional, Stukas, R., additional, Szylling, A., additional, Tan, R., additional, Tibaldi, V., additional, Todo‐Bom, A., additional, Toppila‐Salmi, S., additional, Tomazic, P., additional, Trama, U., additional, Triggiani, M., additional, Valero, A., additional, Valovirta, E., additional, Valiulis, A., additional, Eerd, M., additional, Vasankari, T., additional, Vatrella, A., additional, Ventura, M. T., additional, Verissimo, M. T., additional, Viart, F., additional, Williams, S., additional, Wagenmann, M., additional, Wanscher, C., additional, Westman, M., additional, Wickman, M., additional, Young, I., additional, Yorgancioglu, A., additional, Zernotti, E., additional, Zuberbier, T., additional, Zurkuhlen, A., additional, De Oliviera, B., additional, and Senn, A., additional

Published
2017
Full Text
View/download PDF

10. Digitally enabled health service for the integrated management of hypertension : A participatory user-centred design process

Author

Martino F. Pengo, Strahil Birov, Marie Holm Sherman, Guido Iaccarino, Vincenzo De Luca, Mikael Lilja, Raffaele Izzo, Klaus Piesche, Maddalena Illario, Marcello Melgara, Gianfranco Parati, Maria Triassi, Vanja Lazic, Ozan Beyhan, Antonija Balenovic, De Luca, V, Lazic, V, Birov, S, Piesche, K, Beyhan, O, Pengo, M, Melgara, M, Sherman, M, Lilja, M, Balenovic, A, Parati, G, Triassi, M, Izzo, R, Iaccarino, G, Illario, M, De Luca, V., Lazic, V., Birov, S., Piesche, K., Beyhan, O., Pengo, M. F., Melgara, M., Sherman, M. H., Lilja, M., Balenovic, A., Parati, G., Triassi, M., Izzo, R., Iaccarino, G., and Illario, M.

Subjects
Process management, User-centred design, Service delivery framework, Computer science, Health, Toxicology and Mutagenesis, 030204 cardiovascular system & hematology, chronic care model, 0302 clinical medicine, Health care, health innovation, 030212 general & internal medicine, mHealth, Health Service, integrated care, Chronic care model, Integrated care, Functional requirement, Health Services, 3. Good health, Hypertension, user-centred design, Medicine, Digital health, Human, Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi, hypertension, Health Personnel, digital health, MHealth, Article, 03 medical and health sciences, Procurement, active and healthy aging, Humans, Innovative procurement, Self-monitoring, self-monitoring, innovative procurement, business.industry, Active and healthy aging, Public Health, Environmental and Occupational Health, Information technology, Health Care Service and Management, Health Policy and Services and Health Economy, business, Health innovation, Delivery of Health Care
Abstract

This article describes a user-centred approach taken by a group of five procurers to set specifications for the procurement of value-based research and development services for IT-supported integrated hypertension management. The approach considered the unmet needs of patients and health systems of the involved regions. The procurers established a framework for requirements and a solution design consisting of nine building blocks, divided into three domains: service delivery, devices and integration, and health care organisation. The approach included the development of questionnaires, capturing patients’ and professionals’ views on possible system functionalities, and a template collecting information about the organisation of healthcare, professionals involved and existing IT systems at the procurers’ premises. A total of 28 patients diagnosed with hypertension and 26 professionals were interviewed. The interviewees identified 98 functional requirements, grouped in the nine building blocks. A total of nine use cases and their corresponding process models were defined by the procurers’ working group. As result, a digitally enabled integrated approach to hypertension has been designed to allow citizens to learn how to prevent the development of hypertension and lead a healthy lifestyle, and to receive comprehensive, individualised treatment in close collaboration with healthcare professionals.

Published
2021

11. An Innovative Approach to Designing Digital Health Solutions Addressing the Unmet Needs of Obese Patients in Europe

Author

Maria Triassi, Giuseppe Carruba, Veli N. Stroetmann, Roberta Patalano, Jess Vogt, Vincenzo De Luca, Maddalena Illario, Annamaria Colao, Claudia Pivonello, Strahil Birov, Lucia Giovannelli, Patalano, R., De Luca, V., Vogt, J., Birov, S., Giovannelli, L., Carruba, G., Pivonello, C., Stroetmann, V., Triassi, M., Colao, A., and Illario, M.

Subjects
Obese patient, obesity, healthy life, Health, Toxicology and Mutagenesis, Population, digital health, lcsh:Medicine, 030209 endocrinology & metabolism, Overweight, Article, 03 medical and health sciences, 0302 clinical medicine, Quality of life (healthcare), Health care, medicine, Humans, 030212 general & internal medicine, Marketing, obese patients, education, education.field_of_study, Government, healthy food, business.industry, lcsh:R, Public Health, Environmental and Occupational Health, Digital transformation, Digital health, Europe, Health promotion, nutrition, Quality of Life, Business, medicine.symptom, Delivery of Health Care
Abstract

According to the World Health Organization (WHO), the worldwide obesity rate has tripled since 1975. In Europe, more than half of the population is overweight and obese. Around 2.8 million people die each year worldwide as a result of conditions linked to being overweight or obese. This study aimed to analyze the policies, approaches, and solutions that address the social and health unmet needs of obese patients, at different levels, in order to simulate the definition of an integrated approach, and to provide and share examples of innovative solutions supporting health promotion, disease prevention, and integration of services to improve the collaboration between the different health and care stakeholders involved across the country and in the lives of obese patients. A collaborative approach involving various levels of government and regional experts from different European countries was applied to identify, explore, and evaluate different aspects of the topic, from the innovation perspective and focusing on a European and a regional vision. Currently, people prefer more foods rich in fats, sugars, and salt/sodium than fruits, vegetables, and fiber. This behavior leads to a significant negative impact on their health-related quality of life. Changes in healthcare systems, healthy policy, and approaches to patient care and better implementation of the different prevention strategies between all the stakeholders are needed, taking advantage of the digital transformation of health and care. Such changes can support obese patients in their fight against an unhealthy lifestyle and at the same time reduce healthcare costs.

Published
2020

12. Developing a digital environment for the management of chronic conditions: The proempower experience of a Horizon 2020 PCP for type 2 diabetes

Author

Guido Iaccarino, Adriano Fernandes, Guglielmo Toscano, Maria Triassi, Maria Del Pilar López Acuña, Maddalena Illario, Ozan Beyhan, Giovanni Annuzzi, Reinhard Hammerschmidt, Roberta Patalano, Vincenzo De Luca, Giovanni Tramontano, Simon Robinson, Gorka Sanchez-Nanclares, Strahil Birov, Vincenzo De Luca, Strahil Birov, Ozan Beyhan, Simon Robinson, Gorka Sanchez-Nanclares, Maria Del Pilar López Acuña, Adriano Fernandes, Reinhard Hammerschmidt, Giovanni Tramontano, Roberta Patalano, Guglielmo Toscano, Giovanni Annuzzi, Guido Iaccarino, Maria Triassi & Maddalena Illario, De Luca, V., Birov, S., Beyhan, O., Robinson, S., Sanchez-Nanclares, G., Del Pilar Lopez Acuna, M., Fernandes, A., Hammerschmidt, R., Tramontano, G., Patalano, R., Toscano, G., Annuzzi, G., Iaccarino, G., Triassi, M., and Illario, M.

Subjects
Call for bids, Diabetes mellitu, business.industry, End user, media_common.quotation_subject, Pre-commercial procurement, Technical specifications, 030209 endocrinology & metabolism, Purchasing, 03 medical and health sciences, 0302 clinical medicine, Goods and services, Procurement, 13. Climate action, Information and Communications Technology, ICT, Health care, 030212 general & internal medicine, Prosperity, Marketing, business, Innovation, media_common
Abstract

Demographic change represents the most significant challenge of the 21st century. The aging population around the world will foster a consequent change in labor markets, wealth distribution, request of goods and services, as well as social and healthcare needs. The number of survivors to once deadly conditions, as well as the age associated increase in degenerative chronic conditions will represent a severe stress to our systems, that will not be sustainable any longer. At the same time, longevity might become an opportunity for the re-organization of services, leading to a new era of opportunities for economic and social prosperity. These challenges require a strong interdisciplinary approach in the identification of unmet needs, and new social, health and technological solutions, that are demand-driven and user-oriented. ICT is going to be the key to many of these revolutionary services. The European Community has proposed a new grant instrument to foster the collaboration between public administration and ICT industry for purchasing Research and Development services in order to develop a novel Information and Communication Technology solution, called Pre Commercial Procurement. ProEmpower is such a project aimed to enable patients to early diagnosis, daily management, and clinical data collection for people with type 2 diabetes. The project goes through a call for tenders issued by a consortium of four public procurers, that jointly defined a set of requirements and use cases, in collaboration with end-users, for the development of innovative solutions This manuscript describes the process that has led to the selection of two solutions that will be tested by end users in the four regions.

Published
2020

13. Success Factors for Scaling Up the Adoption of Digital Therapeutics Towards the Realization of P5 Medicine.

Author

Prodan A, Deimel L, Ahlqvist J, Birov S, Thiel R, Toivanen M, Kolitsi Z, and Kalra D

Abstract

Introduction: Digital therapeutics (DTx) can be a valuable contribution to the successful scale up of P5 Medicine (personalized, participatory, predictive, preventive, precision medicine) as they offer powerful means of delivering personalization and active patient participation in disease self-management. We investigated how the approval and adoption of DTx within health systems have been approached in five selected European countries and regions, with a view to proposing success factors scaling up their adoption., Methodology: Preliminary research established best countries or region candidates as being Germany, UK, France, Belgium, and the Spanish Region of Catalonia. The research was informed by a literature review, interviews with public bodies and industry, and a multi-stakeholder workshop to validate the findings and fill in existing gaps., Results: To authorize the use of digital technologies, the countries and regions passed legislation and developed policy instruments, appointed bodies to assess and certify the products and formalized mechanisms for permitting reimbursement. While DTx is not a commonly used nomenclature, there are digital health technology types defined that have similar requirements as DTx. Assessment and certification frameworks are usually built around the Medical Device Regulation with additional criteria. Reimbursement considerations often observe reimbursement of therapeutic devices and/or medicines. To be integrated into reimbursement systems, countries require manufacturers to demonstrate clinical value and cost-effectiveness. As there are currently very few DTx approved in practice, there is resistance toward clinical acceptance and organizational change, and change management is highly needed to integrate DTx into healthcare systems. The integration and secondary use of DTx data is not encountered in daily practice. Although some enablers exist, there remain technical and legal barriers., Discussion: DTx strategies should be considered as an integral part of digital health strategies and legislation, and specific DTx pathways with clear and transparent assessment and guidelines that balance regulation and innovation should be defined. To help manufacturers, countries should recommend and list methods that are widely accepted and ensure scientific robustness, aligned to the MDR requirements to support transfer of relevant and comparable data across countries. To facilitate rapid uptake of innovation, countries should add flexibility to the framework by allowing temporary market authorization to enable data collection that can support the clinical and socio-economic evaluation and data gathering phase. Certification should trigger rapid price setting and reimbursement mechanisms, and dynamic ways to adjust price and reimbursement levels in time should be established. Relevant stakeholders should be approached on the potential impacts of DTx through transparent communication and change management strategies should be considered. These findings should be validated with a wider range of stakeholders., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Prodan, Deimel, Ahlqvist, Birov, Thiel, Toivanen, Kolitsi and Kalra.)

Published
2022
Full Text
View/download PDF

14. Digitally Enabled Health Service for the Integrated Management of Hypertension: A Participatory User-Centred Design Process.

Author

De Luca V, Lazic V, Birov S, Piesche K, Beyhan O, Pengo MF, Melgara M, Sherman MH, Lilja M, Balenovic A, Parati G, Triassi M, Izzo R, Iaccarino G, and Illario M

Subjects
Delivery of Health Care, Health Personnel, Humans, Health Services, Hypertension prevention & control
Abstract

This article describes a user-centred approach taken by a group of five procurers to set specifications for the procurement of value-based research and development services for IT-supported integrated hypertension management. The approach considered the unmet needs of patients and health systems of the involved regions. The procurers established a framework for requirements and a solution design consisting of nine building blocks, divided into three domains: service delivery, devices and integration, and health care organisation. The approach included the development of questionnaires, capturing patients' and professionals' views on possible system functionalities, and a template collecting information about the organisation of healthcare, professionals involved and existing IT systems at the procurers' premises. A total of 28 patients diagnosed with hypertension and 26 professionals were interviewed. The interviewees identified 98 functional requirements, grouped in the nine building blocks. A total of nine use cases and their corresponding process models were defined by the procurers' working group. As result, a digitally enabled integrated approach to hypertension has been designed to allow citizens to learn how to prevent the development of hypertension and lead a healthy lifestyle, and to receive comprehensive, individualised treatment in close collaboration with healthcare professionals.

Published
2021
Full Text
View/download PDF

15. An Innovative Approach to Designing Digital Health Solutions Addressing the Unmet Needs of Obese Patients in Europe.

Author

Patalano R, De Luca V, Vogt J, Birov S, Giovannelli L, Carruba G, Pivonello C, Stroetmann V, Triassi M, Colao A, and Illario M

Subjects
Delivery of Health Care, Europe, Humans, Overweight, Obesity epidemiology, Obesity prevention & control, Quality of Life
Abstract

According to the World Health Organization (WHO), the worldwide obesity rate has tripled since 1975. In Europe, more than half of the population is overweight and obese. Around 2.8 million people die each year worldwide as a result of conditions linked to being overweight or obese. This study aimed to analyze the policies, approaches, and solutions that address the social and health unmet needs of obese patients, at different levels, in order to simulate the definition of an integrated approach, and to provide and share examples of innovative solutions supporting health promotion, disease prevention, and integration of services to improve the collaboration between the different health and care stakeholders involved across the country and in the lives of obese patients. A collaborative approach involving various levels of government and regional experts from different European countries was applied to identify, explore, and evaluate different aspects of the topic, from the innovation perspective and focusing on a European and a regional vision. Currently, people prefer more foods rich in fats, sugars, and salt/sodium than fruits, vegetables, and fiber. This behavior leads to a significant negative impact on their health-related quality of life. Changes in healthcare systems, healthy policy, and approaches to patient care and better implementation of the different prevention strategies between all the stakeholders are needed, taking advantage of the digital transformation of health and care. Such changes can support obese patients in their fight against an unhealthy lifestyle and at the same time reduce healthcare costs.

Published
2021
Full Text
View/download PDF

16. The Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing.

Author

Bousquet J, Illario M, Farrell J, Batey N, Carriazo AM, Malva J, Hajjam J, Colgan E, Guldemond N, Perälä-Heape M, Onorato GL, Bedbrook A, Leonardini L, Stroetman V, Birov S, Abreu C, Abrunhosa A, Agrimi A, Alalääkkölä T, Allegretti N, Alonso-Trujillo F, Álvarez-Benito M, Angioli S, Apóstolo J, Armitage G, Arnavielhe S, Baena-ParejoI M, Bamidis PD, Balenović A, Barbolini M, Baroni I, Blain H, Bernard PL, Bersani M, Berti E, Bogatyrchuk L, Bourret R, Brehm J, Brussino L, Buhr D, Bultje D, Cabeza E, Cano A, De Capitani C, Carantoña E, Cardoso A, Coll Clavero JI, Combe B, Conforti D, Coppola L, Corti F, Coscioni E, Costa E, Crooks G, Cunha A, Daien C, Dantas, Darpón Sierra J, Davoli M, Dedeu Baraldes A, De Luca V, De Nardi L, Di Ciano M, Dozet A, Ekinci B, Erve S, Espinoza Almendro JM, Fait A, Fensli R, Fernandez Nocelo S, Gálvez-Daza P, Gámez-Payá J, García Sáez M, Garcia Sanchez I, Gemicioğlu B, Goetzke W, Goossens E, Geurdens M, Gütter Z, Hansen H, Hartman S, Hegendörfer G, Heikka H, Henderson D, Héran D, Hirvonen S, Iaccarino G, Jansson N, Kallasvaara H, Kalyoncu F, Kirchmayer U, Kokko JA, Korpelainen J, Kostka T, Kuna P, Lajarín Ortega T, Lama CM, Laune D, Lauri D, Ledroit V, Levato G, Lewis L, Liotta G, Lundgren L, Lupiañez-Villanueva F, Mc Garry P, Maggio M, Manuel de Keenoy E, Martinez C, Martínez-Domene M, Martínez-Lozano Aranaga B, Massimilliano M, Maurizio A, Mayora O, Melle C, Mendez-Zorilla A, Mengon H, Mercier G, Mercier J, Meyer I, Millet Pi-Figueras A, Mitsias P, Molloy DW, Monti R, Moro ML, Muranko H, Nalin M, Nobili A, Noguès M, O'Caoimh R, Pais S, Papini D, Parkkila P, Pattichis C, Pavlickova A, Peiponen A, Pereira S, Pépin JL, Piera Jiménez J, Portheine P, Potel L, Pozzi AC, Quiñonez P, Ramirez Lauritsen X, Ramos MJ, Rännäli-Kontturi A, Risino A, Robalo-Cordeiro C, Rolla G, Roller R, Romano M, Romano V, Ruiz-Fernández J, Saccavini C, Sachinopoulou A, Sánchez Rubio MJ, Santos L, Scalvini S, Scopetani E, Smedberg D, Solana-Lara R, Sołtysik B, Sorlini M, Stericker S, Stramba Badiale M, Taillieu I, Tervahauta M, Teixeira A, Tikanmäki H, Todo-Bom A, Tooley A, Tuulonen A, Tziraki C, Ussai S, Van der Veen S, Venchiarutti A, Verdoy-Berastegi D, Verissimo M, Visconti L, Vollenbroek-Hutten M, Weinzerl K, Wozniak L, Yorgancıoğlu A, Zavagli V, and Zurkuhlen AJ

Abstract

Seventy four Reference Sites of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) have been recognised by the European Commission in 2016 for their commitment to excellence in investing and scaling up innovative solutions for active and healthy ageing. The Reference Site Collaborative Network (RSCN) brings together the EIP on AHA Reference Sites awarded by the European Commission, and Candidate Reference Sites into a single forum. The overarching goals are to promote cooperation, share and transfer good practice and solutions in the development and scaling up of health and care strategies, policies and service delivery models, while at the same time supporting the action groups in their work. The RSCN aspires to be recognized by the EU Commission as the principal forum and authority representing all EIP on AHA Reference Sites. The RSCN will contribute to achieve the goals of the EIP on AHA by improving health and care outcomes for citizens across Europe, and the development of sustainable economic growth and the creation of jobs.

Published
2019

17. The Costs and Benefits of SNOMED CT Implementation: An Economic Assessment Model.

Author

Thiel R, Birov S, Piesche K, Højen AR, Gøeg KR, Dewenter H, Nejad RF, Thun S, Volkert P, Kufrin VK, and Stroetmann V

Subjects
European Union, Humans, Cost-Benefit Analysis, Models, Economic, Systematized Nomenclature of Medicine
Abstract

As part of its investigations, the EU-funded ASSESS CT project developed an Economic Assessment Model for assessing SNOMED CT's and other terminologies' socio-economic impact in a systematic approach. Methodology and key elements of the model are presented: cost and benefit indicators for assessing deployment, and a cost-benefit analysis tool to collect, estimate, and evaluate data.

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results